Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I do like a good surge, especially when its the SP :)
https://cannabishealthnews.co.uk/2023/03/30/uk-medical-cannabis-patient-numbers-surge-in-2023/
Who would believe it, cannabis proves to be more effective for chronic pain than other treatments including opioids. All the millions of people who could be given a second chance at life, all they need is all they need is a Kanabo vape pod.
https://cannabishealthnews.co.uk/2023/03/27/a-second-chance-at-life-case-for-medicinal-cannabis-in-chronic-pain/
good news for Kanabo once they have the CE mark
https://cannabishealthnews.co.uk/2023/03/21/medical-cannabis-germany-what-you-need-to-know-new-regulations/
Interesting podcast
https://audioboom.com/posts/8266158-the-sunday-roast-featuring-james-short-ceo-of-celadon-pharmaceuticals-aim-cel-charles-bray
Granted home office licence to sell its product. this is significant, until now the only products available apart from flower had to have been through medical trials, such as Sativex. this opens things up for Kanabo, and maybe a product supply line in the short term for Treat-it.
https://www.ft.com/content/e0954eb4-af0a-45ed-8d43-267de7da7337
Great RNS and it plays into the market needs, these guys know how to build for future growth. Hopefully not too far into the future.
https://businesscann.com/nhs-licensed-medical-cannabis-prescriptions-grew-45-last-year-but-situation-as-intolerable-as-ever/
I have done well here these past weeks, the true spread is narrower as I bought 50k under .038 yesterday. We know the potential for gains here when news lands. I give it at least until June as I am confident they will achieve CE certification. I also find the GP service a very attractive long term play, times are changing and KNB look to be ahead of the game.
All IMHO GL
In the October investor presentation they talk about moving production to the UK in the first half of 2023.By doing so they expect to reduce production costs by 40%. That`s the vape carts not growing the product. So they will need to set up a small production facility if they are going to make good on that objective. That will need to be a sterile environment if its to produce medical grade products. No mention of it this time round but I was thinking this could be a significant cost, would they need to raise funds. not saying its a bad thing just wondering whether any progress has been made in this regard.
Hi Mariusz, Great stuff, I have been making cannabinoid based products for a few years now also seen what vaping them can do for numerous health condition's, but not heard of anything quite like your story. I will do some research see what i can find.
Totaly agree with you regarding Kanabo, fantastic products and a wide open market.
Hi Billy is that an informed view have you done any research. Kanabo was undervalued at the 2p range and is moving up on the expectation of news.
Did you say what news, well its difficult to know what might come first. CE mark for the vape pod, update on the GP platform. You might be lucky and buy in cheaper if the SP falls back, then again you might wake up one day soon to a 7p share price. DYOR and Good luck
Anyone wanting to follow in KNB footsteps have their work cut out, probably be two years behind. They produce high quality CBD and THC based vaping products. They are produced from a combination of cannabinoids and terpenes or from whole plant extractions, with no other additives. Each product is intended to be used to treat a specific need and they will be running trials to get medical approval for some products just as with any medicine. They are well placed to capitalize on any easing of regulatory controls as the medical cannabis market grows. Not just another vape pen IMO.